🇺🇸 High Dose Melphalan in United States

13 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Thrombocytopenia — 3 reports (23.08%)
  2. Hypertension — 2 reports (15.38%)
  3. Acute Myeloid Leukaemia — 1 report (7.69%)
  4. Acute Respiratory Distress Syndrome — 1 report (7.69%)
  5. Blood Urine Present — 1 report (7.69%)
  6. Cholecystitis — 1 report (7.69%)
  7. Colitis — 1 report (7.69%)
  8. Colon Cancer Metastatic — 1 report (7.69%)
  9. Haematuria — 1 report (7.69%)
  10. Haemoglobin Decreased — 1 report (7.69%)

Source database →

Other Oncology approved in United States

Frequently asked questions

Is High Dose Melphalan approved in United States?

High Dose Melphalan does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for High Dose Melphalan in United States?

M.D. Anderson Cancer Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.